Clinical trial
A Canadian Study of Cisplatin mEtabolomics and NephroToxicity
NCT04442516 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Canadian Study of Cisplatin mEtabolomics and NephroToxicity
- Lead sponsor
- The Hospital for Sick Children
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 12, 2020
- Completion date
- December 31, 2028
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, cancer